Ficerafusp alfa
BCA101X301
Phase 3 small_molecule active
Quick answer
Ficerafusp alfa for Metastatic Head and Neck Squamous Cell Carcinoma is a Phase 3 program (small_molecule) at Bicara Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bicara Therapeutics
- Indication
- Metastatic Head and Neck Squamous Cell Carcinoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active